Exploring extracellular vesicles as mediators of clinical disease and vehicles for viral therapeutics: Insights from the COVID-19 pandemic
Open Access
- 19 July 2022
- journal article
- review article
- Published by OAE Publishing Inc. in Extracellular Vesicles and Circulating Nucleic Acids
- Vol. 3 (3) , 172-88
Abstract
The COVID-19 pandemic has challenged researchers to rapidly understand the capabilities of the SARS-CoV-2 virus and investigate potential therapeutics for SARS-CoV-2 infection. COVID-19 has been associated with devastating lung and cardiac injury, profound inflammation, and a heightened coagulopathic state, which may, in part, be driven by cellular crosstalk facilitated by extracellular vesicles (EVs). In recent years, EVs have emerged as important biomarkers of disease, and while extracellular vesicles may contribute to the spread of COVID-19 infection from one cell to the next, they also may be engineered to play a protective or therapeutic role as decoys or “delivery drivers” for therapeutic agents. This review explores these roles and areas for future study.Keywords
Funding Information
- NIH (R01DA040392)
This publication has 133 references indexed in Scilit:
- HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44Journal of Clinical Investigation, 2012
- The ESCRT PathwayDevelopmental Cell, 2011
- The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in MalignancyClinical Cancer Research, 2009
- Coagulation cascadeHemodialysis International, 2006
- C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferationCardiovascular Research, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 BuddingCell, 2001
- Possible involvement of cytokines in diffuse intravascular coagulation and thrombosisBest Practice & Research Clinical Haematology, 1999
- B lymphocytes secrete antigen-presenting vesicles.Journal of Experimental Medicine, 1996